Rosuvastatin in hemodialysis: short-term effects on lipids and C-reactive protein.


BACKGROUND Patients on regular hemodialysis present high cardiovascular mortality. Uremic dyslipidemia and inflammation take part in the etiology of atherosclerosis. Rosuvastatin calcium has not been studied in patients on dialysis to date. We sought to evaluate the results of rosuvastatin therapy regarding lipids, lipoproteins and a marker of inflammation… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.